Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 1.74 and traded as high as GBX 1.79. Proteome Sciences shares last traded at GBX 1.79, with a volume of 14,113 shares traded.
Proteome Sciences Price Performance
The firm has a 50 day moving average of GBX 1.74 and a 200-day moving average of GBX 1.66. The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46. The company has a market cap of £5.24 million, a P/E ratio of -1.44 and a beta of 0.15.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
